BioTuesdays
Geron

Stifel starts Geron at buy; PT $3

Stifel initiated coverage of Geron (NASDAQ:GERN) with a “buy” rating and $3 price target. The stock closed at $1.59 on July 31. Geron is focused on the development and potential commercialization of a single product...

Zenabis Logo

Zenabis names Shai Altman as president and CEO

Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1.  Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief facilities officer. Mr. Altman...

Onconova Logo

Maxim ups Onconova Therapeutics PT to $3 from $1.25

Maxim Group raised its price target for Onconova Therapeutics (NASDAQ:ONTX) to $3 from $1.25 after the company announced that the required number of survival events for the pivotal Phase 3 INSPIRE study of IV rigosertib...

Sierra Oncology

HCW starts Sierra Oncology at buy; PT $20

H.C. Wainwright launched coverage of Sierra Oncology (NASDAQ:SRRA) with a “buy” rating and $20 price target. The stock closed at $12.46 on July 29. Sierra Oncology is in the midst of a Phase 3 MOMENTUM study with its...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.